SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-23-041170
Filing Date
2023-05-18
Accepted
2023-05-18 16:05:11
Documents
1
Period of Report
2023-05-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4475
  Complete submission text file 0001213900-23-041170.txt   5826
Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH DR., STE. 125 ROCKVILLE MD 20850
Business Address
Broder Samuel (Reporting) CIK: 0001340543 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40410 | Film No.: 23936042

Mailing Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017
Business Address ONE VANDERBILT AVENUE, 26TH FLOOR NEW YORK NY 10017 212-303-7822
Orion Biotech Opportunities Corp. (Issuer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks